P
arkinson's disease is one of the most common neurodegenerative disorders, affecting around 2% of the population above 65 years of age. 1 Pathological features include degeneration of dopaminergic neurones of the substantia nigra pars compacta, and the presence of eosinophilic inclusions known as Lewy bodies in affected brain areas. 2 Six genes for monogenically inherited forms of Parkinson's disease, which account for only a small fraction of all Parkinson's disease cases, have been identified. It has been shown that mutations in the parkin gene (PARK2), in the PINK1 gene (PARK6), and in the DJ-1 gene (PARK7) cause autosomal recessive early onset parkinsonism. [3] [4] [5] The asynuclein gene (SNCA) has been implicated in rare forms of dominantly inherited Parkinson's disease (PARK1), either by missense mutations or gene multiplications. [6] [7] [8] Leucine-rich repeat kinase 2 (LRRK2) has been identified as the disease causing gene for late onset autosomal dominant parkinsonism (PARK8). 9 10 In addition, various genetic studies have detected linkage to several other chromosomal regions, for which the disease causing genes have yet to be detected: PARK3 (2p13), PARK9 (1p36), PARK10 (1p32), and PARK11(2q13). 11 Eight genome scans evaluating linkage with affection status as well as with age of onset have been carried out using sibling pair cohorts as well as multiplex families from North American and European populations. [12] [13] [14] [15] [16] [17] [18] We have mapped a locus for autosomal dominant Parkinson's disease on chromosome 2p13 (PARK3) 19 which we further refined to 2.5 megabases. 20 Three other genome scans confirmed the PARK3 locus. 14 16 17 In a refinement of the locus position, DeStefano et al found evidence for association between later Parkinson's disease age at onset and allele 174 of marker D2S1394, which is close to the SPR gene. 18 Karamohamed et al extended the work by genotyping single nucleotide polymorphisms (SNPs) in the vicinity of marker D2S1394. 21 They reported association of one SNP and a haplotype across the SPR gene with age of onset in sibships of North American origin.
Here, we thoroughly assess the SPR gene region in sporadic Parkinson's disease cases ascertained from Germany, and in familial Parkinson's disease samples from five different European countries. After characterising the linkage disequilibrium (LD) structure in the SPR gene region, we further refined association signals for Parkinson's disease susceptibility to haplotypes and SNPs within an LD block comprising the SPR gene.
METHODS
We conducted our study in two parts. First, we genotyped five short tandem repeat (STR) markers and 17 SNPs from the PARK3 core region centred around the SPR gene ( recessive inheritance with early onset (,45 years) in at least one affected member, the parkin, PINK1 and DJ-1 genes were completely sequenced and mutations were excluded.
Recruitment of sporadic Parkinson's disease patients
Parkinson's disease patients were recruited mainly from the departments of neurology at the Universities of Munich and Tübingen. Specialists in movement disorders examined the patients. Diagnosis was established according to UK Brain Bank criteria. 22 The median age at onset was 55.4 years (range ¡19.1). As controls we used 680 healthy, age and sex matched subjects from the KORA (Cooperative Research in the Region of Augsburg) Survey 2000, which involved a large, population based sample.
Genotyping of STRs
We genotyped the five STR markers D2S2110, D2S1394, D2S2111, D2S145, and D2S2109 with an average spacing of 0.2 cM from the PARK3 core region, as defined by West et al.
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The new marker order was obtained from the Marshfield Genetic Laboratories Map. Mendelian inconsistencies in the genotypic data were checked by using the program PedCheck. 23 
Genotyping of SNPs
Within the PARK3 core region we focused on the SPR gene region (4 kb SPR gene plus 94 kb flanking regions; in all 98 kb; see fig 1) . Forty SNPs with an average spacing of 2.5 kb were identified using public databases. All SNPs showed high genotyping quality and Hardy-Weinberg equilibrium in the control subjects. Genotyping was undertaken using the matrix assisted laser desorption/ionisation time of flight (MALDI-TOF) mass spectrometry method (Sequenom, San Diego, California, USA).
Statistical analysis
We used the non-parametric linkage scores (NPL) for the analysis of the sibship data. 24 NPL compares the estimated proportion of alleles shared by identical by descent siblings with the null hypothesis of no linkage. The S all function in Genehunter was used for calculation. The age of onset effect in siblings was tested by the quantitative transmission disequilibrium test (QTDT) using an orthogonal and monks model. 25 This allows one to incorporate pedigrees without parental genotypes. Whenever there are more than two siblings in the families, allelic transmission scores were used to assess the association.
The method of Gabriel et al, as implemented in Haploview, was used to construct LD blocks from SNPs with minor allele frequencies (MAF) of more than 0.05. 26 In the sporadic patients, logistic regression was used to test for association between SNP alleles or haplotypes and Parkinson's disease affection status as implemented in UNPHASED. 27 A stepwise approach was employed to determine which variants independently influence the risk of the disease. This approach allows the effect at a locus to be assessed for conditioning on alleles at other loci. A linear regression model was used to assess the age of onset effect.
RESULTS

Analysis of sibship families
We obtained overall non-parametric LOD scores with affection status of 2.12 and 1.96 at the SPR-neighbouring markers D2S2110 and D2S1394, respectively. After the exclusion of six families with PARK8 mutations the LOD scores increased to 2.76 and 2.08 at these two markers, as shown in table 3.
Family sets from single countries showed the same trend but were underpowered to obtain significant LOD scores except for the UK sample. Seven of the 17 SNPs located between the STR markers D2S2110 and D2S1394 also showed significant LOD scores (table 1) .
We further analysed the age of onset effect in our sibship samples. The STR marker D2S2110 (p = 0.04) and the SNP marker rs1876487 (p = 0.04) showed significant association with age of onset. D2S2110 is the only genotyped STR marker which is located within the SPR LD block described below. The SPR promoter SNP rs1876487 was also associated with age of onset in the study by Karamohamed et al.
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Analysis of sporadic patients Seventeen of the 40 genotyped SNPs had MAF ,0.05 and were excluded from further analysis. In all, 23 SNPs were used in the final analysis. One highly intercorrelated LD block of 45 kb (block A) can be defined around the SPR gene between SNP rs1396107 and rs1161267 (fig 1) . After testing different allelic and genotypic risk effect models, we show only the recessive risk effect model, which best fitted to the observed genotype data. The associated SNPs comprised variants with risk allele frequencies of either ,7% and ,27% in the control population, and were highly intercorrelated, with r 2 values of 0.81 to 0.92. The 11 SNPs with MAF of 7% seem to be more strongly associated than the more common SNPs, which include the SNP rs1876487 identified by Karamohamed et al. The estimated relative risks ranged from 1.21 to 1.57. In a stepwise regression procedure which tested the allelic association of all significant SNPs conditioned on alleles at the other significant loci, we were unable to find an independent signal. It appears that all significant SNPs within block A (fig 1) potentially referred to a single causal variant.
A haplotype within block A with a population frequency of 7.6% was also significantly associated with Parkinson's disease (p = 0.010), as shown in table 5.
Interestingly, this haplotype is differentiated by 11 mutational steps compared with the next related common haplotype (frequency 17.5%) in the same block. This ''YinYang'' pattern of haplotype relations may indicate recent positive or balancing selection operating on the block A variants. 28 We further evaluated the three-locus haplotype (rs2421095-rs1876487-rs1561244) described by Karamohamed et al, 21 which extends between block A and block B (fig 1) . The haplotype AGG, which was most significantly associated with age of onset in Karamohamed's study, was also most significantly associated in our study (p = 0.002; table 6), albeit with affection status.
We found neither single marker nor haplotype association with age of onset in our sporadic Parkinson's disease sample.
DISCUSSION
There is accumulating evidence that the SPR gene is one of the likely candidates for the PARK3 locus. First, in a large sample of multiplex families (the GenePD study), one microsatellite marker D2S1394, which is only 9 kb away from the SPR gene, showed association with Parkinson's disease age at onset. 18 The associated allele ''174'' of this marker is also common to the segregating core haplotype observed in two PARK3 families. 19 20 Second, a haplotype harbouring the SPR gene and the promoter SNP rs1876487 was reported to be associated with onset age in the GenePD study. 21 Third, we obtained significant LOD scores with Parkinson's disease susceptibility at the two microsatellite markers D2S2110 and D2S1394, which encompass the SPR gene, in an independent large sample of multiplex families (European GSPD study). Interestingly, the English families with the highest mean age of onset contributed most to this linkage signal. This result fits well to the finding that the European genome scan reports a prominent linkage peak at the SPR region only for late age of onset families. 17 We also found association with age of onset at the markers D2S2110 and rs1876487 in the GSPD family sample. Fourth, we found association with Parkinson's disease susceptibility at several intercorrelated SNP markers and haplotypes in an LD block spanning the SPR gene in a German sample of patients with sporadic Parkinson's disease.
Given all converging evidence, DNA variant(s) in or around the SPR gene appear to influence Parkinson's disease onset. Coding regions of potential PARK3 candidate genes including SPR have been screened for pathogenic mutations in Parkinson's disease families. 20 The failure to detect such mutations could indicate that the functional variant affects expression or splicing regulation rather than the protein structure itself.
A recently published study has revealed a mutation in the 59 UTR of the SPR gene responsible for causing dopa responsive dystonia. 29 SPR is an interesting candidate gene because it catalyses the conversion of 6-pyrovyl-tetrahydropterin (PTP) to tetrahydrobiopterin (BH4). Previous studies have shown that BH4 acts not only as a cofactor for TH4 and is therefore important for dopamine biosynthesis, but also stimulates NOS isoforms (inducible (iNOS), neural (NOS), and endothelial (eNOS)). 30 It has been suggested that iNOS confers protection to Parkinson's disease.
Across studies, there is some variability of the Parkinson's disease phenotype mapped to the SPR region. Whereas the GenePD studies report associations with Parkinson's disease onset age, 18 the study based on the European GSPD samples reveals associations with Parkinson's disease susceptibility. Of note, however, we could also directly replicate the age of onset effect at the promoter marker rs1876487 found by Karamohamed et al. 21 It is obvious that affection status and age of onset are related phenotypes in late onset disorders that show preclinical and postclinical progression. A factor that influences the preclinical history of Parkinson's disease (for example, the start and rate of the progression of neuronal loss) will affect the onset age of Parkinson's disease if a progression threshold is assumed for the transition from healthy to disease status. As general mortality (independent of Parkinson's disease) increases with age, an age of onset factor may also be seen as a susceptibility factor, because early onset factors are upweighted in an association study dealing with affection status. Different age structures in the analysed samples may shift the emphasis (detectability) between the extremes of pure age of onset and pure susceptibility effects.
In summary, we show that the SPR gene is a likely PARK3 candidate. The association signal appears to be confined to a haplotype block of 45 kb surrounding the SPR gene. Our data suggest a single risk variant or age of onset factor of about 7% frequency with a relative risk of about 1.4 within haplotype block A. Further evidence of this association signal comes from the haplotype pattern, which is indicative for recent natural selection in this genomic region. 31 
ELECTRONIC DATABASE INFORMATION
The URLs for the data presented in this paper are as follows: 
